Inactive

Solicitation W81K00-22-Q-0109 was issued on Thursday, 14 July 2022. Offers are due by 28 July 2022, 1:00 PM, Central Standard Time (unless extended via amendment). Offers shall be submitted via e-mail... Solicitation W81K00-22-Q-0109 was issued on Thursday, 14 July 2022. Offers are due by 28 July 2022, 1:00 PM, Central Standard Time (unless extended via amendment). Offers shall be submitted via e-mail to Medina.L.Woodson.civ@mail.mil and Randall.P.Cummins.civ@mail.mil. Quotes received after the deadline will be considered untimely and will not be eligible for award. The deadline for questions is 21 July 2022, 4:00 PM, Central Standard Time (questions submitted after this deadline will not be answered). All questions must be submitted in writing to Medina.L.Woodson.civ@mail.mil and Randall.P.Cummins.civ@mail.mil. All offerors shall provide the following items: Completed SF 1449: Blocks 12, 17 (to include CAGE code and DUNS number), 30A - C Completed SF 30: Blocks 8, 15A - C (for all amendments issued, if any) Point of Contact Information (Name, Telephone Number, Fax Number, and Email) Statement that the offeror will hold its quote firm for at least 90 days from the due date for receipt of quotes, subject to any changes that may occur as a result of discussions (if applicable). Completed provisions, as listed in the solicitation. Alternately, complete all provisions in SAM and provide confirmation of completion and accuracy with offer. Potential contractors must be registered in the System for Award Management (SAM) to be eligible for award. The SAM website is http://www.sam.gov. Electronic submissions with files larger than 20MB will need to be submitted in separate emails. All emails, regardless of the size, need to be received by the Government server, by the stated date and time. It is the offeror's responsibility to ensure the Government receives the entire quote.

Inactive

Solicitation W81K00-22-Q-0109 will be issued NLT 18 July 2022, 4:00 PM, Central Standard Time (unless extended via amendment). Offers shall be submitted via e-mail to Medina.L.Woodson.civ@mail.mil and... Solicitation W81K00-22-Q-0109 will be issued NLT 18 July 2022, 4:00 PM, Central Standard Time (unless extended via amendment). Offers shall be submitted via e-mail to Medina.L.Woodson.civ@mail.mil and Randall.P.Cummins.civ@mail.mil. Quotes received after the deadline will be considered untimely and will not be eligible for award. The deadline for questions will be 22 July 2022, 4:00 PM, Central Standard Time (questions submitted after this deadline will not be answered). All questions must be submitted in writing to Medina.L.Woodson.civ@mail.mil and Randall.P.Cummins.civ@mail.mil. Electronic submissions with files larger than 20MB will need to be submitted in separate emails. All emails, regardless of the size, need to be received by the Government server, by the stated date and time. It will be the offeror's responsibility to ensure the Government receives the entire quote.

Inactive

Sources Sought Notice – Cost-Per-Test- Flow Cytometry Testing: Reagents and Instrumentation The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of San Anto... Sources Sought Notice – Cost-Per-Test- Flow Cytometry Testing: Reagents and Instrumentation The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of San Antonio Military Medical Center, JBSA - Fort Sam Houston, Texas. Any responses to this Sources Sought Notice will be used for planning purposes only. This notice is not a solicitation of binding offers, nor is it a notice to proceed. The San Antonio Military Medical Center (SAMMC) has a requirement for a Cost-Per-Test Agreement to include reagents instrument/equipment, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to conduct testing to include: CDC Basic panel, Leukemia/Lymphoma, and Stem Cell/CD34 for the Core lab Department at the Brooke Army Medical Center (BAMC) in Fort Sam Houston TX. Flow cytometry can identify the type of cells in a blood or bone marrow sample, including the types of cancer cells. It detects the type of cancer cells based on either the presence or the absence of certain protein markers (antigens) on a cell’s surface. The most common use of flow cytometry is in the identification of markers on cells, particularly in the immune system (called immunophenotyping). The CDC Basic panel is used to monitor disease progression of HIV/AIDS and the efficacy of treatment. Leukemia/Lymphoma are also monitored for disease progression and treatment efficacy with flow cytometry. Vendors that consider themselves capable of providing the required testing are invited to submit a capability statement for the Government to consider via email to the Point of Contact listed herein. This capability statement shall include the following information. If the capability statement does not address ALL of the points below, the vendor will not be considered as capable of providing the required testing: Vendor name (to include CAGE code and DUNS number); Point of Contact (to include email address and phone number); business size. 2. Documentation that demonstrates its ability to provide Cost-Per-Test Agreement to include reagents equipment, Consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to conduct testing to include: CDC Basic panel, Leukemia/Lymphoma, and Stem Cell/CD34. a. Vendor name (to include CAGE code and DUNS number); Point of Contact (to include email address and phone number); business size. b. Documentation that demonstrates its ability to provide Cost-Per-Test Agreement to include reagents instrument/equipment, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to conduct testing to include: CDC Basic panel, Leukemia/Lymphoma, and Stem Cell/CD34. C. Food and Drug Administration (FDA) approval if applicable. c. Food and Drug Administration (FDA) approval if applicable. Capability Statement (limited to ten pages), describing how your company meets the below objectives, providing additional proof (such as FDA approval) where appropriate: Basic Requirements: The analyzers and its components to include the workstation should not exceed the following dimensions (7.5 ft. wide, 2.5 feet deep and 2 ft. high) and should be a tabletop analyzer. There is no floor space for anything larger than a tabletop. Please see the attached Sources Sought Notice for the Cost-Per-Test- Flow Cytometry Testing: Reagents and Instrumentation. The response due date for this Sources Sought Notice is 1:00 PM CST, 23 May 2022. All questions and comments regarding this announcement shall be submitted via e-mail to the below POCs: